title: Syndrome of inappropriate secretion of antidiuretic hormone due to desvenlafaxine.
abstract: OBJECTIVE
  Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is not uncommon in patients receiving treatment of selective serotonin reuptake inhibitors or venlafaxine.
  
  
  METHODS
  This is a case report of a 47-year-old man with depression, who developed hyponatremia after commencing treatment with desvenlafaxine.
  
  
  RESULTS
  To our knowledge, this is the first case in which desvenlafaxine-associated SIADH was reported since the introduction of the drug.
  
  
  CONCLUSIONS
  Physicians should be aware of the possibility of desvenlafaxine-associated hyponatremia in patients under age of 65.
authors: Department of Psychiatry, United Christian Hospital, Hong Kong. Electronic address: leetinho@hotmail.com.
authors: Gary tin-ho
authors: Gt
authors: Lee
authors: Jess lam-ming
authors: Jl
authors: Leung
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy; D000069468:Desvenlafaxine Succinate; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged
chemical_list: D000928:Antidepressive Agents; D003511:Cyclohexanols; D000069468:Desvenlafaxine Succinate